不同BMI分类下COPD患者低去脂体重的差异化影响:COSYCONET研究
结果显示低FFMI频率从低BMI到高BMI组递减,去脂体重仅在低体重组与6分钟步行距离独立相关。
要点
- 低FFMI频率随BMI升高而降低(低体重81%、正常体重53%、超重前期42%、肥胖39%)。
- 去脂体重仅低体重组与6MWD独立相关,调整协变量后P<.05。
- 脂肪量在正常体重及超重前期组与更高系统性炎症相关(P<.05)。
核心结论
- 低体重COPD患者中较高FFMI独立关联更好运动能力。
- 超重前期和肥胖COPD患者中较高FFMI未一致关联更好结局。
研究设计与样本
- 按BMI分为低体重、正常体重、超重前期和肥胖组,并按参考值第25和75百分位将FFMI分为低、正常和高。
- 采用线性混合模型分析各BMI组中去脂体重和脂肪量与次要结局的关联。
主要发现
- 低体重、正常体重、超重前期和肥胖组比例分别为12.3%、31.3%、39.6%和16.8%。
- 低FFMI频率从低到高BMI组递减:低体重81%、正常体重53%、超重前期42%、肥胖39%。
- 去脂体重在低体重组与6MWD相关,调整广泛协变量后仍显著(P<.05)。
- 调整肺功能或呼吸困难后,HRQL与去脂体重无关联(P>.32)。
- 正常体重和超重前期组中脂肪量与更高系统性炎症相关(P<.05)。
临床怎么用
- 对低体重COPD患者,评估去脂体重可能有助于识别运动能力受损风险。
- 超重前期和肥胖COPD患者中,提高FFMI未必改善结局,需综合评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alterations in body composition, including a low fat-free mass index (FFMI), are common in patients with COPD and occur regardless of body weight. RESEARCH QUESTION: Is the impact of low FFMI on exercise capacity, health-related quality of life (HRQL), and systemic inflammation different among patients with COPD stratified in different BMI classifications? STUDY DESIGN AND METHODS: We analyzed baseline data of patients with COPD from the COPD and Systemic Consequences-Comorbidities Network (COSYCONET) cohort. Assessments included lung function, bioelectrical impedance analysis, 6-min walk distance (6MWD), HRQL, and inflammatory markers. Patients were stratified in underweight, normal weight (NW), preobese, and obese according to BMI and as presenting low, normal, or high FFMI using 25th and 75th percentiles of reference values. Linear mixed models were used to investigate the associations between fat-free mass (FFM) and fat mass with secondary outcomes in each BMI group. RESULTS: Two thousand one hundred thirty-seven patients with COPD (Global Initiative for Chronic Obstructive Lung Disease stages 1-4; 61% men; mean ± SD age, 65 ± 8 years; mean ± SD FEV1, 52.5 ± 18.8% predicted) were included. The proportions of patients in underweight, NW, preobese, and obese groups were 12.3%, 31.3%, 39.6%, and 16.8%, respectively. The frequency of low FFMI decreased from lower to higher BMI groups (underweight, 81%; NW, 53%; preobese, 42%; and obese, 39%). FFM was associated with the 6MWD in the underweight group, even when adjusting for a broad set of covariates (P < .05). HRQL was not associated with FFM after adjustment for lung function or dyspnea (P > .32). Fat mass was associated with higher systemic inflammation in the NW and preobese groups (P < .05). INTERPRETATION: In patients with COPD with lower weight, such as underweight patients, higher FFMI is associated independently with better exercise capacity. In contrast, in preobese and obese patients with COPD, a higher FFMI was not consistently associated with better outcomes.
引用
- Machado FVC, Vogelmeier CF, Jörres RA, et al. Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications: Results From the COPD and Systemic Consequences-Comorbidities Network. Chest. 2022. PMID: 36470414. doi:10.1016/j.chest.2022.11.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。